GHK-Cu vs HGH 191AA
Head-to-head comparison of GHK-Cu and HGH 191AA for research applications. Both peptides are studied for various research applications, but they differ significantly in mechanism, evidence level, and dosing protocols.
Side-by-Side Comparison
| Attribute | Ghk Cu | Hgh 191aa |
|---|---|---|
| Category | Skin & Tissue Repair | Growth Hormone |
| Mechanism | GHK-Cu chelates copper(II) ions via its histidine residue and delivers bioavailable copper directly to cells, preventing free copper oxidative damage. | HGH 191AA binds to the growth hormone receptor (GHR) on target cells, triggering JAK2-STAT5 signaling, which drives transcription of IGF-1 and other growth factors. |
| Evidence Rating | F — No Regulatory Activity | A — FDA Approved |
| Clinical Status | Available in cosmetic formulations; no drug approval | FDA-approved (multiple indications). Numerous brand-name products available worldwide. |
| Safety Profile | Safety profile is excellent with minimal side effects reported in decades of cosmetic use and clinical research (PMID: 29986520); Topical forms are generally well-tolerated; mild skin irritation rare and typically limited to very sensitive skin | Common: injection site reactions, fluid retention, joint pain/stiffness, carpal tunnel syndrome; Metabolic: insulin resistance, hyperglycemia (dose-dependent), may precipitate diabetes |
| Route | Subcutaneous, Topical (cream/serum), or Intradermal (microneedling) | Subcutaneous injection |
| Dose Range | SC: 50–200 mcg/day; Topical: 1–4% cream or serum applied to target area | 0.15-2 mg per injection (0.5-6 IU) |
| Frequency | SC: Once daily; Topical: 1–2x daily | Once daily |
| Molecular Weight | ~403.9 g/mol | ~22,124 g/mol |
| Half-Life | ~30 minutes plasma | ~3-5 hours (SC) |
Overview
GHK-Cu and HGH 191AA are both research peptides studied across multiple applications. This comparison examines their mechanisms, evidence base, dosing protocols, and safety profiles to help researchers understand the key differences and overlaps.
GHK-Cu — Mechanism & Evidence
GHK-Cu is a naturally occurring copper-binding tripeptide (glycyl-L-histidyl-L-lysine) found in human plasma, saliva, and urine. First discovered by Dr. Loren Pickart in 1973, plasma levels average 200 ng/mL at age 20 but decline to ~80 ng/mL by age 60. It has been extensively studied for wound healing, collagen synthesis, skin regeneration, and gene modulation, with decades of cosmetic use and a broad safety profile. Molecular weight is approximately 340 g/mol (as the copper complex), with the formula C14H24N6O4Cu.
Key claims: Improves skin firmness and elasticity; Promotes wound healing; Reduces fine lines and wrinkles.
HGH 191AA — Mechanism & Evidence
HGH 191AA refers to recombinant human growth hormone (somatropin) — a 191-amino acid, single-chain polypeptide (MW ~22,124 g/mol) identical in sequence to endogenous pituitary growth hormone. In the peptide community, "191AA" distinguishes legitimate somatropin from the older 192-amino acid variant (somatrem, which had an extra methionine and higher immunogenicity).
Key claims: Treats growth hormone deficiency; Improves body composition in GH-deficient adults; Anti-aging and rejuvenation effects in healthy elderly.
Shared Research Applications
These peptides target different research areas. GHK-Cu focuses on Skin Health, Anti-Aging, Wound Healing, while HGH 191AA targets Anti-Aging & Longevity, Body Composition.
Safety Considerations
GHK-Cu: Safety profile is excellent with minimal side effects reported in decades of cosmetic use and clinical research (PMID: 29986520) Topical forms are generally well-tolerated; mild skin irritation rare and typically limited to very sensitive skin Injectable forms: mild injection site reactions, lightheadedness, nausea, flu-like symptoms possible; rotate injection sites to reduce local irritation
HGH 191AA: Common: injection site reactions, fluid retention, joint pain/stiffness, carpal tunnel syndrome Metabolic: insulin resistance, hyperglycemia (dose-dependent), may precipitate diabetes Endocrine: gynecomastia, hypothyroidism (may unmask central hypothyroidism)
Shop Research Peptides
GHK-Cu 50mg
50mg
BPC-157 5mg
5mg
Retatrutide 20mg
20mg
Retatrutide 10mg
10mg
Tesamorelin 10mg
10mg
BPC-157 10mg
10mg
Tirzepatide 10mg
10mg
KPV 10mg
10mg
Quality Documentation
Review batch documentation before making research purchasing decisions. Volta pairs product education with COA literacy so researchers can evaluate purity, identity, lot details, and testing context.
Product cards on this page link to current catalog entries and available quality documentation.
Related Research News
GHK-Cu in Research: Reconstitution, Stability, and Handling Guide
This guide covers the essentials of working with GHK-Cu in a research setting, from reconstitution math and solvent choice to stability and purity considerations. Learn how to handle copper peptides correctly and what to verify before starting a study.
GHK-Cu and Hair Follicle Growth: A Review of Copper Peptide Dermatological Research
Explore the preclinical evidence on GHK-Cu for hair follicle growth, including proposed mechanisms and research limitations.
Synergistic Regeneration: BPC-157, Thymosin Beta-4, and GHK-Cu in Healing Research
Explore the synergistic potential of BPC-157, Thymosin Beta-4, and GHK-Cu in regenerative research. Preclinical evidence and mechanisms reviewed.